# The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

> **NCT04221672** · PHASE3 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 86 (estimated)

## Conditions studied

- Terlipressin Adverse Reaction
- Ascites Hepatic
- Liver Failure
- Acute Kidney Injury

## Interventions

- **DRUG:** Terlipressin plus standard care
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT04221672
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-07
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221672, "The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04221672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*